Journal of Immune Based Therapies, Vaccines and Antimicrobials

Volume 2, Issue 1 (January 2013)

ISSN Print: 2168-1546   ISSN Online: 2168-1554

Citations  

Overcome the Impairment of NK Cells for Icon and Antibody Immunotherapy of Cancer

HTML  XML Download Download as PDF (Size: 192KB)  PP. 1-8  
DOI: 10.4236/jibtva.2013.21001    4,738 Downloads   10,181 Views  Citations
Author(s)

ABSTRACT

Natural killer (NK) cells play an important role in innate immunity and in mediating antibody and Icon (an antibody-like factor VII/IgG1 Fc immunoconjugate, which, to our best knowledge, was the first therapeutic agent for dual targeting of both the tumor cells and tumor angiogenic endothelial cells) for cancer immunotherapy. However, a common yet often neglected observation and challenge in antibody immunotherapy is that NK cells are often impaired in cancer patients. Here we hypothesize that the impairment of NK cells significantly contributes to host resistance to antibody immunotherapy for cancer. In order for antibody and Icon to achieve their optimal therapeutic efficacy, we briefly reviewed the current strategies to enhance NK activity, including infusion of cytokines, vaccines or NK cells, and the use of dietary supplements. Moreover, from our point of view we identified some remaining challenges and propose to combine these NK-enhancing strategies with Icon or antibody to overcome NK impairment and ultimately to optimize the efficacy of Icon and antibody immunotherapy for cancer.

Share and Cite:

Hu, Z. (2013) Overcome the Impairment of NK Cells for Icon and Antibody Immunotherapy of Cancer. Journal of Immune Based Therapies, Vaccines and Antimicrobials, 2, 1-8. doi: 10.4236/jibtva.2013.21001.

Cited by

[1] A high-throughput RNAi screening identifies olfactory receptor signaling as a novel immune checkpoint in solid tumors
2023
[2] Using CAR-NK cells to overcome the host resistance to antibody immunotherapy and immune checkpoint blockade therapy
Successes and Challenges of NK Immunotherapy, 2021
[3] Tissue factor as a new target for CAR-NK cell immunotherapy of triple-negative breast cancer
2020
[4] Dissecting the NK cell population in hematological cancers confirms the presence of tumor cells and their impact on NK population function
2020
[5] Investigating the maintenance of desmoid tumors beyond beta-catenin
2019
[6] Non-genetically improving the natural cytotoxicity of natural killer (NK) cells
2019
[7] Therapeutic antibody-like immunoconjugates against tissue factor with the potential to treat angiogenesis-dependent as well as macrophage-associated …
Antibodies, 2018
[8] Therapeutic antibody-like immunoconjugates against tissue factor with the potential to treat angiogenesis-dependent as well as macrophage-associated human …
Antibodies, 2018
[9] Expansion of allogeneic nk cells with efficient antibody-dependent cell cytotoxicity against multiple tumors
Theranostics, 2018
[10] The future of immune checkpoint blockade immunotherapy: towards personalized therapy or towards combination therapy
Journal of thoracic disease, 2017

Copyright © 2025 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.